Experimental chemotherapy of filariasis: comparative evaluation of the efficacy of filaricidal compounds in Mastomys coucha infected with Litomosoides carinii, Acanthocheilonema viteae, Brugia malayi and B. pahangi.
Abstract |
Eleven types/classes of compound with antifilarial activity were comparatively evaluated in Mastomys coucha infected with Litomosoides carinii, Acanthocheilonema viteae, Brugia malayi or B. pahangi. The paper deals with the efficacy of (i) predominantly microfilaricidal compounds [ diethylcarbamazine, levamisole, avermectins ( ivermectin, milbemycin), nitrofurans ( nitrofurantoin, hydroxymethylnitrofurantoin, nifurtimox, furazolidone, furapyrimidone), organophosphorals ( metrifonate, haloxon), and aminophenyl- amidines], (ii) predominantly macrofilaricidal compounds [ suramin, benzimidazoles ( flubendazole, mebendazole, oxfendazole, ciclobendazole, albendazole, cambendazole, fenbendazole), and arsenicals ( thiacetarsamide, Mel PH, R7/45)], and (iii) micro- and macrofilaricidal compounds [benzazole derivatives ( CGP 20376 and other benzothiazoles) and nitrophenylamines ( amoscanate, CGP 6140)]. Minimum effective doses against microfilariae and minimum curative doses against adult filariae as well as detailed data on dose-efficacy relationships are reported for the various drugs. The results obtained in M. coucha are compared with those published for other experimental in vivo filarial systems, thus attempting to describe a general status of in vivo antifilarial activity of the compounds.
|
Authors | H Zahner, G Schares |
Journal | Acta tropica
(Acta Trop)
Vol. 52
Issue 4
Pg. 221-66
(Jan 1993)
ISSN: 0001-706X [Print] Netherlands |
PMID | 8094587
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
|
Topics |
- Animals
- Brugia
(drug effects)
- Dipetalonema Infections
(drug therapy)
- Filariasis
(drug therapy)
- Filaricides
(classification, therapeutic use)
- Humans
- Muridae
(parasitology)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|